The Baby Makers: Critics Push for Regulation of India's Booming Surrogacy Industry
By ABC,
ABC
| 04. 15. 2014
As more than 800 million Indians go to the polls this month, the main political party candidates are being urged to finally push through legislation to regulate the country's booming commercial surrogacy industry.
The calls come as increasing numbers of foreigners, including many Australians, pay thousands of dollars to Indian surrogacy centres to fulfil their need to have children.
The industry has been criticised for operating in a regulatory vacuum, and while there are some rules for people who take the journey to India, it is still a minefield for many unsuspecting parents.
Author and critic Kishwar Desai has strong reservations about the lack of legal oversight and what it means for the women who rent out their wombs.
"We're treating these women like animals, like you would do with cattle ... so I think that is something we need to be very careful about," she said.
"It's not the numbers of the women who die - and indeed we may not even know about them because a lot of the clinics are operating without any regulation, without any rules...
Related Articles
By Nick Paul Taylor, BioSpace | 03.14.2024
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...
By Anna Collinson, Maryam Ahmed and Bella McShane, BBC | 03.12.2024
Women who freeze their eggs are being misled by some UK clinics about their chances of having a baby, a fertility charity says.
The Fertility Network was reacting to BBC analysis that found 41% of clinics offering the service privately...
By Isabelle Bartram, Guest Contributor
| 03.13.2024
Note: This article was originally published in February 2024 in issue 268 of the German-language journal Der Gen-ethische Informationsdienst (GID). It is also part of an English-language dossier on Heritable Human Genome Editing published at the same time. Minor edits have been made.
Calls for German embryo research
Pressure on the German Embryo Protection Act is growing. The scientific community is launching a renewed attack on the controversial law and demands access to embryos for so-called high-ranking research objectives. "Germline therapies" are...
By Andrew Joseph, STAT | 02.22.2024
In the years leading up to Russia’s invasion, Ukraine had become a burgeoning hub of clinical trials, particularly in oncology. The war put a hold on the vast majority of those studies.
But as the country marks two years this...